Pan-cancer analysis shows that TRIP13 as a potential prognostic and immunotherapeutic biomarker for multiple cancer types including LIHC and LUAD
Abstract Growing evidence indicates that thyroid hormone receptor interactor 13 (TRIP13) plays an oncogenic role in various malignancies. Pan-cancer analysis…